Thyroid hormone modulation of rat sulphotransferase mRNA expression

References

• BARTER, R. A. and KLAASSEN, C. D., 1992, UDP-glucuronosyltransferase inducers reduce thyroid hormone levels in rats by an extrathyroidal mechanism. Toxicology and Applied Pharmacology, 113, 36–42.
   PubMed Web of Science ®Google Scholar
• BORTHWICK, E. B., VOICE, M. W., BURCHELL, A. and COUGHTRIE, M. W., 1995, Effects of hypo-physectomy and thyroxine on the expression of hepatic oestrogen, hydroxysteroid and phenol sulphotransferases. Biochemical Pharmacology, 49, 1381–1386.
   PubMedGoogle Scholar
• CLISSOLD, S. P. and HEEL, R. C., 1987, Topical minoxidil. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in alopecia areata and alopecia androgenetica. Drugs, 33, 107–122.
   PubMed Web of Science ®Google Scholar
• DEBAUN, J. R., MILLER, E. C. and MILLER, J. A., 1970, N-hydroxy-2-acetylaminofluorene sulpho-transferase: its probable role in carcinogenesis and in protein-(methion-S-y0 binding in rat liver. Cancer Research, 30, 577–595.
   PubMed Web of Science ®Google Scholar
• DEMYAN, W. F., SONG, C. S., KIM, D. S., HER, S., GALLWITZ W., RAO, T. R., SLOMCZYNSKA M., CHATTERJEE, B. and ROY, A. K., 1992, Estrogen sulphotransferase of the rat liver: complementary DNA cloning and age- and sex-specific regulation of messenger RNA. Molecular Endocrinology, 6, 589–597.
   Google Scholar
• FUJITA, K., NAGATA, K., OZAWA, S., SASANO, H. and YAMAZOE, Y., 1997, Molecular cloning and characterization of rat ST1B1 and human ST1B2 cDNAs, encoding thyroid hormone sulfo-transferases . Journal of Biochemistry (Tokyo), 122, 1052–1061.
   PubMed Web of Science ®Google Scholar
• GONG, D. W., MURAYAMA, N., YAMAZOE, Y. and KATO, R., 1992, Hepatic triiodothyronine sulphation and its regulation by growth hormone and triio do thyronine in rats. journal of Biochemistry Tokyo, 112, 112–116.
   PubMedGoogle Scholar
• GOON, D. and KLAASSEN, C. D., 1990, Dose-dependent intestinal glucuronidation and sulphation of acetaminophen in the rat in situ. Journal of Pharmacology and Experimental Therapeutics, 252, 201–207.
   PubMedGoogle Scholar
• GREGUS, Z., MADHU, C. and KLAASSEN, C. D., 1988, Species variation in toxication and detoxication of acetaminophen in vivo: a comparative study of biliary and urinary excretion of acetaminophen metabolites. Journal of Pharmacology and Experimental Therapeutics, 244, 91–99.
   PubMed Web of Science ®Google Scholar
• HELLRIEGEL, E. T., MAIWYSHYN, G. A., FEI, P., DRAGNEV, K. H., Nis, R. W., LUBET, R. A. and KONG, A. N., 1996, Regulation of gene expression of various phase I and phase II drug-metabolizing enzymes by tamoxifen in rat liver. Biochemical Pharmacology, 52, 1561–1568.
   PubMed Web of Science ®Google Scholar
• JONES, P.M., BURIUN, J. M., GHATEI, M. A., O'HALLORAN, D. J., LEGON, S., and BLOOM, S. R., 1990, The influence of thyroid hormone status on the hypothalamo-hypophyseal growth hormone axis. Endocrinology, 126, 1374–1379.
   Google Scholar
• KATO, R. and YAMAZOE, Y., 1992, Sex-specific cytochrome P450 as a cause of sex- and species-related differences in drug toxicity. Toxicology Letters, 64–65, 661–667.
   Google Scholar
• LEVY, A., MATOVELLE, M. C., LIGHTMAN, S. L. and YOUNG, W. S., 1992, The effects of pituitary stalk transection, hypophysectomy and thyroid hormone status on insulin-like growth factor 2-, growth hormone releasing hormone, and somatostatin mRNA prevalence in rat brain. Brain Research, 579, 1–7.
   PubMedGoogle Scholar
• Liu, L. and KLAASSEN, C. D., 1996a, Different mechanism of saturation of acetaminophen sulphate conjugation in mice and rats. Toxicology and Applied Pharmacology, 139, 128–134.
   PubMed Web of Science ®Google Scholar
• Liu, L. and KLAASSEN, C. D., 1996b, Ontogeny and hormonal basis of male-dominant rat hepatic sulphotransferases. Molecular Pharmacology, 50, 565–572.
   PubMedGoogle Scholar
• Liu, L. and KLAASSEN, C. D., 1996c, Ontogeny and hormonal basis of female-dominant rat hepatic sulphotransferases. Journal of Pharmacology and Experimental Therapeutics, 279, 386–391.
   PubMed Web of Science ®Google Scholar
• Liu, L. and KLAASSEN, C. D., 1996d, Regulation of hepatic sulphotransferases by steroidal chemicals in rats. Drug Metabolism and Disposition, 24, 854–858.
   PubMed Web of Science ®Google Scholar
• MEERMAN, J. H. N. and VANDEPOLL, M. L. M., 1994, Metabolic activation routes of arylamines and their genotoxic effects. Environmental Health Perspectives, 102, 153–159.
   Google Scholar
• MULDER, G. J., JAKOBY, W. B. and MULDER, G. J. (eds), 1990, Sulphation. In Conjugation Reactions in Drug Metabolism (London: Taylor & Francis), pp. 107–161.
   Google Scholar
• MURAYAMA, N., SHIMADA, M., YAMAZOE, Y. and KATO, R., 1991, Difference in the susceptibility of two phenobarbital-inducible forms, P45011B1 and P450I1B2, to thyroid hormone- and growth hormone-induced suppression in rat liver: phenobarbital-inducible P450I1B2 suppression by thyroid hormone acting directly, but not through the pituitary system. Molecular Pharmacology, 39, 811–817.
   PubMed Web of Science ®Google Scholar
• NAGATA, K., OZAWA, S., MIYATA, M., SHIMADA, M., GONG, D. W., YAMAZOE, Y. and KATO, R., 1993, Isolation and expression of a cDNA encoding a male-specific rat sulphotransferase that catalyzes activation of N-hydroxy-2-acetylaminofluorene. Journal of Biological Chemistry, 268, 24720–24725.
   PubMed Web of Science ®Google Scholar
• NUWAYS1R, E. F., DAGGETT, D. A., JORDAN, V. C. and Pout, H. C., 1996, Phase II enzyme expression in rat liver in response to the antiestrogen tamoxifen. Cancer Research, 56, 3704–3710.
   PubMedGoogle Scholar
• OGURA, K., KAJTTA, J., NARIFIATA, H., WATABE, T., OZAWA, S., NAGATA, K., YAMAZOE, Y. and KATO, R., 1989, Cloning and sequence analysis of a rat liver cDNA encoding hydroxysteroid sulpho-transferase. Biochemical and Biophysical Research Communication, 165, 168–174.
   PubMedGoogle Scholar
• OGURA, K., KAJTTA, J., NARIFIATA, H., WATABE, T., OZAWA, S., NAGATA, K., YAMAZOE, Y. and KATO, R., 1990, cDNA cloning of the hydroxysteroid sulphotransferase STa sharing a strong homology in amino acid sequence with the senescence marker protein SMP-2 in rat livers. Biochemical Biophysical Research Communications, 166, 1494–1500.
   PubMed Web of Science ®Google Scholar
• OZAWA, S., NAGATA, K., GONG, D., YAMAZOE, Y. and KATO, R., 1990, Nucleotide sequence of a full-length cDNA (PST-1) for aryl sulphotransferase from rat liver. Nucleic Acids Research, 18, 4001.
   PubMed Web of Science ®Google Scholar
• RAM, P. A. and WAxisiAN, D. J., 1991, Hepatic P450 expression in hypothyroid rats: differential responsiveness of male-specific P450 forms 2a (IIIA2), 2c (I IC11), and RLM2 (11A2) to thyroid hormone. Molecular Endocrinology, 5, 13–20.
   PubMedGoogle Scholar
• RUNGE -MORAN, M., ROSE, K. and KOCAREK, T. A., 1996, Regulation of rat hepatic sulphotransferase gene expression by glucocorticoid hormones. Drug Metabolism and Disposition, 24, 1095–1101.
   PubMedGoogle Scholar
• RUNGE -MORAN, M. and WiLusz, J., 1994, Suppression of hydroxysteroid sulphotransferase-a gene expression by 3 -methylcholanthrene. Toxicology and Applied Pharmacology, 125, 133–141.
   PubMedGoogle Scholar
• SAKAKIBARA, Y., TAKAMI, Y., ZWIEB, C., NAKAYAMA, T., SU1K0, M., NAKAJIMA, H. and Liu, M. C., 1995, Purification, characterization, and molecular cloning of a novel rat liver Dopa/tyrosine sulphotransferase. Journal of Biological Chemistry, 270, 30470–30478.
   Google Scholar
• SINGLETON, D. W., LEI, X. D., WEBB, S. J., PROUGH, R. A. and GEOGHEGAN, T. E., 1999, Cytochrome P-450 mRNAs are modulated by dehydroepiandrosterone,nafenopin, and triiodothyronine. Drug Metabolism and Disposition, 27, 193–200.
   PubMedGoogle Scholar
• SKETT, P. and WEIR, A., 1983, Sex- and substrate-dependent effects of the thyroid gland on drug metabolism in the rat. Biochemical Pharmacology, 32, 3115–3117.
   PubMed Web of Science ®Google Scholar
• SURH, Y. J., LAI, C. C., MILLER, J. A. and MILLER, E. C., 1987, Hepatic DNA and RNA adduct formation from the carcinogen 7 -hydroxymethyl-12 -methylbenz[a] anthracene and its electro-philic sulphuric acid ester metabolite in preweanling rats and mice. Biochemical and Biophysical Research Communications, 144, 576–582.
   PubMed Web of Science ®Google Scholar
• THOMAS, R. C. and HARPOOTLIAN, H., 1975, Metabolism of minoxidil, a new hypotensive agent II: biotransformation following oral administration to rats, dogs, and monkeys. Journal of Pharmacological Science, 64, 1366–1371.
   PubMed Web of Science ®Google Scholar
• UEDA, R., SHEMADA, M., HASHIMOTO, H., IsHixAwA, H. and YAMAZOE, Y., 1997, Distinct regulation of two hydroxysteroid sulphotransferases, ST2A1 and ST2A2, by growth hormone: a unique type of growth hormone regulation in rats. Journal of Pharmacology and Experimental Therapeutics, 282, 1117–1121.
   PubMedGoogle Scholar
• VISSER, T. J., 1994, Role of sulphation in thyroid hormone metabolism. Chemico and Biological Interactions, 92, 293–303.
   PubMed Web of Science ®Google Scholar
• WATABE, T., OG-15RA, K., SATSUKAWA, M., OKUDA, H. and H1RATSUKA, A., 1994, Molecular cloning and functions of rat liver hydroxysteroid sulfotransferases catalysing covalent binding of carcinogenic polycyclic arylmethanols to DNA. Chemico and Biological Interactions, 92, 87–105.
   Google Scholar
• WEBB, S. J., XIAO, G. H., GEOGHEGAN, T. E. and PROUGH, R. A., 1996, Regulation of CYP4A expression in rat by dehydroepiandrosterone and thyroid hormone. Molecular Pharmacology, 49, 276–287.
   PubMed Web of Science ®Google Scholar
• YAMAZOE, Y., MANABE S., MURAYAMA, N. and KATO, R., 1987, Regulation of hepatic sulfotransferase catalyzing the activation of N-hydroxyarylamide and N-hydroxyarylamine by growth hormone. Molecular Pharmacology, 32, 536–541.
   Google Scholar
• YAMAZOE, Y., GONG, D., MURAYAMA, N., Asti-ZEto, M. and KATO, R., 1989, Regulation of hepatic cortisol sulfotransferase in rats by pituitary growth hormone. Molecular Pharmacology, 35, 707–712.
   Google Scholar
• YAMAZOE, Y., MANABE S., MURAYAMA, N. and KATO, R., 1997, Regulation of hepatic sulphotransferase catalyzing the activation of N-hydroxylamide and N-hydroxylarylamine by growth hormone. Molecular Pharmacology, 32, 536–541.
   Google Scholar